Lomovskaya
Irina Aleksandrovna Lomovskaya, Novosibirsk RU
Patent application number | Description | Published |
---|---|---|
20150240612 | Acid Fracturing With Shapeable Materials - Elongated shapeable particles, for example bi-component fibers that are reshaped into tighter structures when heated, are injected into fractures generated during acid fracturing. Collections of such particles form as the temperature in the fracture increases, heterogeneously masking portions of the fracture faces and causing differential etching and increased fracture conductivity when formation-dissolving agents contact the fracture faces. Optionally, the elongated shapeable particles may decompose to release formation-dissolving agents. | 08-27-2015 |
Irina Alexandrovna Lomovskaya, Novosibirsk RU
Patent application number | Description | Published |
---|---|---|
20150344772 | WELL TREATMENT - A method to treat a subterranean formation penetrated by a wellbore, comprising: providing a treatment slurry comprising a carrying fluid, a solid particulate, an agglomerant and an agglomerant aid; injecting the treatment slurry into a fracture to form a mixture of the solid particulate and the agglomerant; and transforming the mixture into areas that are rich in solid particulate and areas that are substantially free of solid particulate. Also disclosed are a composition comprised of the carrying fluid, solid particulate, agglomerant and agglomerant aid, as well as a method of designing a well treatment therewith and a system to form conductive channels in a fracture. | 12-03-2015 |
Olga Lomovskaya, Mill Valley, CA US
Patent application number | Description | Published |
---|---|---|
20100040560 | AEROSOLIZED FLUOROQUINOLONES AND USES THEREOF - Disclosed herein are formulations of fluoroquinolones suitable for aerosolization and use of such formulations for aerosol administration of fluoroquinolone antimicrobials for the treatment of pulmonary bacterial infections. In particular, inhaled levofloxacin specifically formulated and delivered for bacterial infections of the lungs is described. Methods include inhalation protocols and manufacturing procedures for production and use of the compositions described. | 02-18-2010 |
20100166673 | AEROSOLIZED FLUOROQUINOLONES AND USES THEREOF - Disclosed herein are formulations of fluoroquinolones suitable for aerosolization and use of such formulations for aerosol administration of fluoroquinolone antimicrobials for the treatment of pulmonary bacterial infections. In particular, inhaled levofloxacin specifically formulated and delivered for bacterial infections of the lungs is described. Methods include inhalation protocols and manufacturing procedures for production and use of the compositions described. | 07-01-2010 |
Olga Lomovskaya, Mountain View, CA US
Patent application number | Description | Published |
---|---|---|
20080318957 | POLYBASIC BACTERIAL EFFLUX PUMP INHIBITORS AND THERAPEUTIC USES THEREOF - Disclosed are compounds having polybasic functionalities. The compounds inhibit bacterial efflux pump inhibitors and are used in combination with an anti-bacterial agent to treat or prevent bacterial infections. These combinations can be effective against bacterial infections that have developed resistance to anti-bacterial agents through an efflux pump mechanism. | 12-25-2008 |
20120165276 | QUATERNARY ALKYL AMMONIUM BACTERIAL EFFLUX PUMP INHIBITORS AND THERAPEUTIC USES THEREOF - Disclosed are compounds having at least one quaternary alkyl ammonium functionality. The compounds inhibit bacterial efflux pump inhibitors and are used in combination with an anti-bacterial agent to treat or prevent bacterial infections. These combinations can be effective against bacterial infections that have developed resistance to anti-bacterial agents through an efflux pump mechanism. | 06-28-2012 |
20120276153 | USE OF AEROSOLIZED LEVOFLOXACIN FOR TREATING CYSTIC FIBROSIS - Methods for treating cystic fibrosis. The method includes administering to a human in need thereof an aerosol solution comprising levofloxacin or ofloxacin and a divalent or trivalent cation. More particularly, the method includes administering the aerosol solution to a human having a pulmonary infection comprising | 11-01-2012 |